- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05124782
Virtual Management of Rheumatoid Arthritis (ePRAT)
December 30, 2022 updated by: Assistance Publique - Hôpitaux de Paris
Evaluation of Rheumatoid Arthritis at the Time of Telemedicine
The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will be organized in two consecutive steps:
- A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.
- The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Marie BENHAMMANI-GODARD
- Phone Number: 00 33 1 58 41 11 90
- Email: marie.godard@aphp.fr
Study Contact Backup
- Name: Jérôme AVOUAC, MD, PhD
- Phone Number: 00 33 1 58 41 25 86
- Email: jerome.avouac@aphp.fr
Study Locations
-
-
IDF
-
Paris, IDF, France, 75014
- Recruiting
- Rheumatology Department, Cochin Hospital
-
Contact:
- Jérôme AVOUAC, MD, PhD
- Phone Number: 00 33 1 58 41 25 86
- Email: jerome.avouac@aphp.fr
-
Principal Investigator:
- Jérôme Avouac
-
Sub-Investigator:
- Yannick ALLANORE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)
Description
Inclusion Criteria:
- Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
- Follow-up in the rheumatology department of Cochin Hospital
- Affiliated with a social security scheme
- Non-opposition to participating in the study
- Patients with a valid email address (registration to the virtual consultation system)
Exclusion Criteria:
- Opposition to participate to this research
- Inability to understand or speak French
- Patient under tutor or curator ship
- patients under medical state help
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with rheumatoid arthritis
Patients seen in virtual consultation
|
Rheumatoid Arthritis Impact of Disease questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of face to face consultation, hospitalization and therapeutic modifications
Time Frame: Inclusion
|
The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation
|
Inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jérôme Avouac, MD, PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2021
Primary Completion (Anticipated)
November 1, 2023
Study Completion (Anticipated)
March 1, 2024
Study Registration Dates
First Submitted
October 22, 2021
First Submitted That Met QC Criteria
November 15, 2021
First Posted (Actual)
November 18, 2021
Study Record Updates
Last Update Posted (Actual)
January 3, 2023
Last Update Submitted That Met QC Criteria
December 30, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210550
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
David Grant U.S. Air Force Medical CenterCompleted
-
TcLand Expression S.A.European CommissionTerminatedRheumatoId ArthritisFrance, Netherlands, Turkey, Czechia, Israel
Clinical Trials on Rheumatoid Arthritis Impact of Disease questionnaire
-
Trakya UniversityCompletedQuality of Life | Rheumatoid Arthritis | Depression, Anxiety | Nurse's RoleTurkey
-
University Hospital Center of MartiniqueCompletedStudy of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis (HLAPRPA)Rheumatoid ArthritisMartinique
-
Weill Medical College of Cornell UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingCardiovascular Diseases | Rheumatoid Arthritis | HyperlipidemiasUnited States
-
Alliancells Bioscience Corporation LimitedUnknownRheumatoid ArthritisChina
-
Bezmialem Vakif UniversityCompleted
-
Bezmialem Vakif UniversityCompleted
-
Shinshu UniversityShowa Inan General HospitalRecruiting
-
Gaziosmanpasa Research and Education HospitalRecruiting
-
Kutahya Health Sciences UniversityCompletedChronic Pain | Juvenile Idiopathic ArthritisTurkey
-
Tianjin Medical University Second HospitalRecruiting